slow responder to semaglutide The GLP-1 Troubleshooting Guide: Science-Based Solutions for Semaglutide, Tirzepatide, and Other GLP-1s for Respond, (Paperback) The Boom in New Weight

Even though the risk was more than doubled, the overall risk of developing wet AMD was very low: only 93 patients taking GLP-1 medications developed wet AMD after three years among over 46,000 patients in the study

The Bottom Line Whether or not you are breastfeeding, using a GLP-1 medication in the postpartum period is a personal decision that deserves careful consideration

The key is making sure both prescribers are communicating and that the patient is being monitored appropriately

For diabetes management, the standard dose is 1.8 mg injected daily, while for weight loss, the dose is increased to 3 mg daily.10 Titration begins at 0.6 mg/day, increasing weekly by 0.6 mg until the 3 mg maintenance dose is reached, typically over a five-week period.10 Clinical guidelines recommend liraglutide for long-term use when combined with lifestyle modifications